Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence

Figure 4

(a) CCNB1, (b) ESPL1, (c) CENPM, (d) BLM, and (e) ASPM were 4.795-, 5.028-, 8.691-, 2.083-, and 3.725-fold higher in BC than in normal tissues ( = 3.86E−13, 5.92E−20, 5.91E−26, 5.19E−14, and 2.56E−13, respectively).

(a)

(b)

(c)

(d)

(e)